| Financial Year |
March 31 2023 |
| Monetary Funds |
2,139,173,446.07 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
182,042,660.44 |
| Accounts Receivable |
1,677,237,652.01 |
| Advances to Suppliers |
533,571,701.04 |
| Other Receivables |
150,725,739.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,917,532,686.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,448,992.36 |
| Other Current Assets |
42,371,077.69 |
| Total Current Assets |
9,449,450,048.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
3,308,340.80 |
| Long-term Equity Investment |
7,614,069.97 |
| Investment Properties |
464,465.90 |
| Fixed Assetes |
46,427,175.66 |
| Under-construction Projects |
161,840,554.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,215,623.87 |
| R&D expenses |
21,899,986.22 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,015,611.53 |
| Deferred Income Tax Assets |
154,488,755.22 |
| Other Non-Current Assets |
5,722,389.47 |
| Sub-Total of Non-Current Assets |
931,245,561.21 |
| Total Assets |
10,380,695,609.29 |
| Short-Term Loans |
168,125,445.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,597,344.47 |
| Accounts Payable |
1,717,116,868.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,059,408.86 |
| Taxes Payable |
68,359,241.59 |
| Interest Payable |
-- |
| Dividend Payable |
174,524.00 |
| Other payables |
90,135,605.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
74,216,626.99 |
| Other Current Liabilities |
39,328,121.06 |
| Sub-Total of Current Liabilities |
5,617,940,346.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,578,104.85 |
| Deferred Income Tax Liabilities |
59,642,181.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
391,858,982.16 |
| Total Liabilities |
6,009,799,328.93 |
| Paid-In Capital(Or Share Stock) |
685,074,346.00 |
| Capital Surplus |
272,634,261.13 |
| Surplus Reserve |
155,736,283.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,091,177,928.04 |
| Minority Stockholder's Interest |
201,895,129.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,169,001,151.11 |
| Owner's Equity（Stockholder's Equity） |
4,370,896,280.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,380,695,609.29 |
